Literature DB >> 28170157

Combining electrospinning and cell sheet technology for the development of a multiscale tissue engineered ligament construct (TELC).

Cedryck Vaquette1, P T Sudheesh Kumar2, Eugen Bogdan Petcu2,3, Saso Ivanovski2.   

Abstract

Ligament tissue rupture is a common sport injury. Although current treatment modalities can achieve appropriate reconstruction of the damaged ligament, they present significant drawbacks, mostly related to reduced tissue availability and pain associated with tissue harvesting. Stem cell based tissue regeneration combined with electrospun scaffolds represents a novel treatment method for torn ligaments. In this study, a low fiber density polycaprolactone (PCL) electrospun mesh and sheep mesenchymal stem cells (sMSCs) were used to develop tissue engineered ligament construct (TELC) in vitro. The assembly of the TELC was based on the spontaneous capacity of the cells to organize themselves into a cell sheet once seeded onto the electrospun mesh. The cell sheet matured over 4 weeks and strongly integrated with the low fiber density electrospun mesh which was subsequently processed into a ligament-like bundle and braided with two other bundles to develop the final construct. Live/dead assay revealed that the handling of the construct through the various phases of assembly did not cause significant difference in viability compared to the control. Mechanical evaluation demonstrated that the incorporation of the cell sheet into the braided construct resulted in significantly modifying the mechanical behavior. A stress/displacement J-curve was observed for the TELC that was similar to native ligament, whereas this particular feature was not observed in the non-cellularized specimens. The regenerative potential of the TELC was evaluated ectopically in immunocompromized rats, compared to non cellularized electrospun fiber mesh and this demonstrated that the TELC was well colonized by host cells and that a significant remodelling of the implanted construct was observed.
© 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 399-409, 2018. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  anterior cruciate ligament; braiding; cell sheet; electrospinning; tissue engineering; tissue remodelling

Mesh:

Substances:

Year:  2017        PMID: 28170157     DOI: 10.1002/jbm.b.33828

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  5 in total

1.  Development of hydroxyapatite-coated nonwovens for efficient isolation of somatic stem cells from adipose tissues.

Authors:  Ryota Chijimatsu; Taiga Takeda; Shinsaku Tsuji; Kohei Sasaki; Koichi Kato; Rie Kojima; Noriko Michihata; Toshiya Tsubaki; Aya Matui; Miharu Watanabe; Sakae Tanaka; Taku Saito
Journal:  Regen Ther       Date:  2022-06-08       Impact factor: 3.651

2.  Multiphasic scaffold for scapholunate interosseous ligament reconstruction: A study in the rabbit knee.

Authors:  Hayman Lui; Cedryck Vaquette; Janet M Denbeigh; Randy Bindra; Sanjeev Kakar; Andre J van Wijnen
Journal:  J Orthop Res       Date:  2020-07-07       Impact factor: 3.102

Review 3.  Biofabrication of Electrospun Scaffolds for the Regeneration of Tendons and Ligaments.

Authors:  Alberto Sensini; Luca Cristofolini
Journal:  Materials (Basel)       Date:  2018-10-12       Impact factor: 3.623

4.  Cruciate Ligament Cell Sheets Can Be Rapidly Produced on Thermoresponsive poly(glycidyl ether) Coating and Successfully Used for Colonization of Embroidered Scaffolds.

Authors:  Ingrid Zahn; Daniel David Stöbener; Marie Weinhart; Clemens Gögele; Annette Breier; Judith Hahn; Michaela Schröpfer; Michael Meyer; Gundula Schulze-Tanzil
Journal:  Cells       Date:  2021-04-12       Impact factor: 6.600

Review 5.  3D Electrospun Nanofiber-Based Scaffolds: From Preparations and Properties to Tissue Regeneration Applications.

Authors:  Shanshan Han; Kexin Nie; Jingchao Li; Qingqing Sun; Xiaofeng Wang; Xiaomeng Li; Qian Li
Journal:  Stem Cells Int       Date:  2021-06-17       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.